Atlas Trials

Study of Single and Multiple Ascending Doses of ZE46-0134 in Healthy Volunteers

Clinical trial NCT06399315 · COMPLETED

Trial details

NCT number
NCT06399315
Sponsor
Lomond Therapeutics Holdings, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
AML
Start date
2023-07-28
Primary completion
2025-06-30
Enrollment
112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.